Norman Biomed secured €300 million funding commitment to develop low-cost mRNA vaccines

Normax Biomed has secured a €300 million funding commitment to develop low-cost mRNA vaccines.

Dublin Airport Logistics Park was chosen to host the first of 100 vaccine factories the Irish-headquartered biotechnology company intends to develop.

Read the full article below.

Get the Latest News & Events

Our community is growing rapidly, and we want you to be a part of it. Subscribe to our newsletter today by entering your email and signing up!

This field is for validation purposes and should be left unchanged.